NLRP3 and acute respiratory distress syndrome: The current study provides experimental evidence that Ap -in different doses- as a potential pharmacological tool for ameliorating ALI induced via HIR through its anti-inflammatory, antioxidant, anti-apoptotic properties, as well as its modulation of the NLRP3 inflammasome/ IL-1β pathway that could reveal other potential drugs in further research studies.